Lentiviral vectors for gene therapy of HIV-induced disease

Current Topics in Microbiology and Immunology

Volumn 261, Issue , 2002, Pages 229-243

  Amado, R G ^a   Chen, I S Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR;

ANIMAL MODEL; GENE EXPRESSION; GENE THERAPY; HEMATOPOIETIC CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHESUS MONKEY; SCID MOUSE; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRUS; MACACA MULATTA;

EID: 0036201637     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-56114-6_12     Document Type: Review

References (63)

1. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone
2. Modeling human lymphoid precursor cell gene therapy in the SCID-hu mouse
3. Reconstitution of human thymic implants is limited by human immunodeficiency virus breakthrough during antiretroviral therapy
4. A phase I trial of autologous CD34+ hematopoietic progenitor cells transduced with an anti-HIV ribozyme
5. A phase I trial of autologous CD34+ cells transduced with an anti-HIV ribozyme
6. High-efficiency transduction of human lymphoid progenitor cells and expression in differentiated T cells
7. An inducible human immunodeficiency virus type 1 (HIV-1) vector which effectively suppresses HIV-1 replication
8. Marking and gene expression by a lentiviral vector in transplanted human and non-human primate CD34+ cells
9. Long-term in vivo expression of a murine adenosine deaminase gene in rhesus monkey hematopoietic cells of multiple lineages after retroviral mediated gene transfer into CD34+ bone marrow cells
10. RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication
11. Interaction of human immunodeficiency virus-derived vectors with wild-type virus in transduced cells
12. Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors
13. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
14. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection
15. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo
16. Lentiviral-mediated gene transfer into human lymphocytes: Role of HIV-1 accessory proteins
17. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine
18. Anti-HIV effects of HIV vectors
19. Reduction in SIV replication in rhesus macaques infused with autologous lymphocytes engineered with antiviral genes
20. Efficient transduction of human lymphocytes and CD34+ cells via human immunodeficiency virus-based gene transfer vectors
21. Potent inhibition of human immunodeficiency virus type I replication by an intracellular anti-Rev single-chain antibody
22. Lentivirus vector mobilization and spread by human immunodeficiency virus
23. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
24. Simian immunodeficiency virus as a model of human HIV disease
25. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice
26. In vivo pathogenesis of a human immunodeficiency virus type 1 reporter virus
27. Separation of pluripotent haematopoietic stem cells from spleen colon-forming cells
28. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors
29. Long-term in vivo expression of the MFG-ADA retroviral vector in rhesus monkeys transplanted with transduced bone marrow cells
30. Inactivation of a GFP retrovirus occurs at multiple levels in long-term repopulating stem cells and their differentiated progeny
31. A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34(+) cells from the bone marrow of human immunodeficiency virus-1-infected children
32. T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates
33. Human immunodeficiency virus type 1-induced hematopoietic inhibition is independent of productive infection of progenitor cells in vivo
34. Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells
35. Residual human immunodeficiency virus type 1 RNA in lymphoid tissue of patients with sustained plasma RNA of < 200 copies/mL
36. Human immunodeficiency virus infection of cells arrested in the cell cycle
37. Inhibition of human immunodeficiency virus type I replication by regulated expression of a polymeric tat activation response RNA decoy as a strategy for gene therapy in AIDS
38. Inhibition of HIV-1 replication using a mutated tRNALys-3 primer
39. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection
40. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector
41. Development of a self-inactivating lentivirus vector
42. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors
43. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
44. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector
45. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts
46. Fate of the human immunodeficiency virus type 1 provirus in infected cells: A role for vpr
47. High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: Implication for gene therapy of AIDS
48. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors
49. Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individuals
50. Intrinsic human immunodeficiency virus type 1 resistance of hematopoietic stem cells despite coreceptor expression
51. The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells
52. Establishment of a stable, inducible form of human immunodeficiency virus type I DNA in quiescent CD4 lymphocytes in vitro
53. Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation
54. Resistance to human immunodeficiency virus type 1 infection conferred by transduction of human peripheral blood lymphocytes with ribozyme, antisense, or polymeric trans-activation response element constructs
55. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability
56. HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells
57. Inhibition of clinical human immunodeficiency virus (HIV) type 1 isolates in primary CD4+ T lymphocytes by retroviral vectors expressing anti-HIV genes
58. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes
59. Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes
60. Long-term in vivo expression of the human glucocerebrosidase gene in nonhuman primates after CD34+ hematopoietic cell transduction with cell-free retroviral vector preparations
61. Phenotypic knockout of HIV type 1 chemokine coreceptor CCR-5 by intrakines as potential therapeutic approach for HIV-1 infection
62. HIV-1 genome nuclear import is mediated by a central DNA flap
63. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery